![Travis Murdoch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Travis Murdoch
No open positions remaining
Net worth: 168 M $ as of 2026-09-29
Profile
Travis Murdoch was the founder of HIBio, Inc. (founded 2021) serving as Chief Executive Officer & Director.
Dr. Murdoch is the founder of Monograph Capital Advisors (UK) LLP (founded 2021) serving as Partner.
Dr. Murdoch was the founder of Human Immunology Biosciences, Inc. (founded 2021) serving as Chief Executive Officer & Director.
Dr. Murdoch is the founder of Ollin Biosciences, Inc. (founded 2022) serving as Director.
Current jobs include President, Chief Executive Officer & Director at Braveheart Bio, Inc. starting 2025, and Director at Svf Excalibur Cayman Ltd. starting 2020.
Former jobs include Director at Karius, Inc. from 2020 to 2023; Director at Guardant Health AMEA, Inc. from 2019 to 2022; Independent Director at Zymergen, Inc. from 2020 to 2022; Consultant at McKinsey & Co., Inc. from 2015 to 2017; Principal at Third Rock Ventures LLC from 2017 to 2018; and Advisor at SB Investment Advisers (UK) Ltd. from 2021 to 2022.
Education includes graduate degree from the University of Oxford conferred in 2008, and undergraduate and doctorate degrees from the University of Alberta conferred in 2004 and 2009 respectively.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
9.26% | 2026-08-06 | 8,333,637 ( 9.26% ) | 168 M $ | 2026-09-29 |
Travis Murdoch active positions
| Companies | Position | Start |
|---|---|---|
Svf Excalibur Cayman Ltd. | Director/Board Member | 2020-07-28 |
Monograph Capital Advisors (UK) LLP
 Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Founder | 2020-12-31 |
Former positions of Travis Murdoch
| Companies | Position | End |
|---|---|---|
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Founder | 2024-04-30 |
Karius, Inc.
 Karius, Inc. Medical/Nursing ServicesHealth Services Operates as a clinical metagenomics that focused on elevating patient care through microbial insights | Director/Board Member | 2022-12-31 |
| ZYMERGEN INC. | Director/Board Member | 2022-09-30 |
SB Investment Advisers (UK) Ltd.
 SB Investment Advisers (UK) Ltd. Investment ManagersFinance Softbank Vision invests in technology companies across the Globe. The firm acquires minority and majority interests in both private and public companies with a minimum investment size of $100 million. | Consultant / Advisor | 2022-01-30 |
Guardant Health AMEA, Inc.
 Guardant Health AMEA, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Director/Board Member | 2022-01-30 |
Education of Travis Murdoch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It provides financing for early stage capital requirements. The firm also acts as lead investor. | Finance |
Zymergen, Inc.
 Zymergen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that designs and develops genomics products | Health Technology |
SB Investment Advisers (UK) Ltd.
SB Investment Advisers (UK) Ltd. Investment ManagersFinance Softbank Vision invests in technology companies across the Globe. The firm acquires minority and majority interests in both private and public companies with a minimum investment size of $100 million. | Finance |
Karius, Inc.
Karius, Inc. Medical/Nursing ServicesHealth Services Operates as a clinical metagenomics that focused on elevating patient care through microbial insights | Health Services |
Guardant Health AMEA, Inc.
Guardant Health AMEA, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Svf Excalibur Cayman Ltd. | |
HIBio, Inc.
 HIBio, Inc. BiotechnologyHealth Technology Develops transformative therapies | Health Technology |
Monograph Capital Advisors (UK) LLP
Monograph Capital Advisors (UK) LLP Investment ManagersFinance Monograph Capital invests in companies located in the United Kingdom. The firm targets companies operating in the fields of the biotechnology and healthcare sectors. It provides financing for early and growth stage capital requirements. | Finance |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing therapies for immune-mediated diseases | Health Technology |
- Stock Market
- Insiders
- Travis Murdoch
